Compounds analogous to thalidomide from the class comprising pip

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546221, A01N 4340

Patent

active

06110941&

ABSTRACT:
Compounds analogous to thalidomide from the class comprising piperidine-2,6-diones are described, as are a method of preparing them and their use in drugs.

REFERENCES:
patent: 5356406 (1994-10-01), Ciganek et al.
patent: 5463063 (1995-10-01), Muller
patent: 5480892 (1996-01-01), Ciganek et al.
patent: 5698579 (1997-12-01), Muller
Muller et al., J. Med. Chem., 39: 3238-40 (1996).
Teubert et al., Arch. Pharm. Pharm. Med. Checm., 331: 7-12 (1998).
Chemical Abstracts 66: 94788a (1967).
Chemical Abstracts 123: 216835b (1995).
Chemical Abstracts 124: 45119r (1996).
Masuda et al., "Double-Masked Trial of Cyclosporin Versus Colchicine and Long-Term Open Study of Cyclosporin in Behcet's Disease", The Lancet, May 20, 1989, pp. 1093-1095.
G. Tappeiner, "Therapie des Lupus Erythematodes 1994", (Therapy of Lupus Erythematosus 1994), H+G, vol. 69, 1994, pp. 816-822.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compounds analogous to thalidomide from the class comprising pip does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds analogous to thalidomide from the class comprising pip, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds analogous to thalidomide from the class comprising pip will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1250296

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.